Results 31 to 40 of about 125,761 (305)
SLE and α-SLE driven by Lévy processes
The Annals of Probability, 2008 34 ...
Guan, Qing-Yang, Winkel, Matthias
openaire +5 more sources
Autoimmunity, 2020 Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by abnormal T and B cells. B-cell activating factor (BAFF) has been suggested to play a crucial role in lupus by promoting the proliferation, differentiation, and survival ...
Yongjian Chen +6 more
doaj +1 more source
Abstracts, 2021 Case 1: 9-year-old female with rash and oral ulcer Alexandre Belot Alisson is 9 years old and came to the outpatient unit with a rash and oral ulcer. Her past medical history highlighted two invasive infections (meningitidis and pneumonia). She had no muscular weakness, no lymphoproliferative disease and no fever. Her laboratory exams revealed: WBC:
David A. Isenberg +2 more
openaire +3 more sources
Journal of Blood Medicine, 2021 Amel Awad Ibn Idris Rodwan,1 Osama Khder Ahmed Elmansour,1,2 Amar F Eldow Ahmed,3 Elnour Mohammed Elagib,1,4 Noha Ibrahim Ahmed Eltahir,4,5 Abubaker Hassan,6 Sara M El-Sadig,7 Abdel Gaffar Abdel Allah Mohammed,8 Huyam H Awadalla,9 Abubakr Abdalwahab ...
Ibn Idris Rodwan AA +10 more
doaj
Inhibitory B cell co-receptors and autoimmune diseases
Immunological Medicine, 2019 B cells express various inhibitory co-receptors including CD22 (also known as Siglec-2), Siglec-10 (Siglec-G in mice), CD72, LILRB (PIR-B in mice) and FcγRIIB that contain immunoreceptor tyrosine-based inhibition motifs (ITIMs) in the cytoplasmic region ...
Takeshi Tsubata
doaj +1 more source
(NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus
Frontiers in Immunology, 2022 BackgroundSystemic lupus erythematosus (SLE) is a chronic autoimmune/inflammatory disease. The heterogeneity and complexity of clinical presentation has made it challenging to study or treat this syndrome.
Ruqayyah J. Almizraq +7 more
doaj +1 more source
Antimalarials and their association with remission, damage and glucocorticoid use in Systemic Lupus Erythematosus [PDF]
, 2023 openIntroduction: Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease with a protean clinical phenotype. Antimalarials (AMs) are a cornerstone in SLE treatment, and over the years have been associated with many benefits.
MERRA, NOEMI
core
, 2021 Systemic lupus erythematosus (SLE) is a systemic autoimmune disease associated with neuro-psychiatric (NP) manifestations. Frequency and patterns of neuro-psychiatric systemic lupus erythematosus (NPSLE) vary substantially between patients.
Wirth, C. +8 more
core +1 more source
Advancing Stroke Clinical Trials Using Community Engagement and Implementation Science Approaches
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Stroke clinical trials are essential for advancing stroke care but can face challenges with recruitment, retention, clinical relevance, and translation into real‐world practice. We propose that integrating community engagement and implementation science approaches into stroke trials can help address these needs.
Lesli E. Skolarus +2 more
wiley +1 more source
A study of CD11b rs1143679 gene polymorphism in Egyptian systemic lupus erythematosus patients
Journal of the Arab Society for Medical Research, 2023 Background/aim The exact cause of systemic lupus erythematosus (SLE), an autoimmune disorder, is still vague. However, it is believed that its pathogenesis could be a result of the interplay between genetics and the environment.
Mona E Fouda +4 more
doaj +1 more source